PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Cethexonium→

Cethexonium PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
6810-42-0
Molecular formula
C24H50NO+
Molecular weight
368.7 g/mol
Drug class
Ganglionic nicotinic acetylcholine receptor antagonisthistorical antihypertensive
Mechanism of action
Blocks neuronal nicotinic acetylcholine receptors in autonomic ganglia, reducing sympathetic and parasympathetic transmission and producing marked autonomic blockade.
Indications / reported uses
  • Historical use for severe hypertension before modern antihypertensive agents became available; not a routine contemporary treatment and current medicinal authorisation is not established

Sources: NLM MeSH — Cethexonium · PubMed — Cethexonium ganglionic blocker · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Cethexonium PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Cethexonium Permitted Daily Exposure (PDE) report (the Cethexonium PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Cethexonium Occupational Exposure Limit (OEL) report (the Cethexonium OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.